Sponsored by
The Musella Foundation helped fund this research looking at how different treatment options affect length of survival for children with DIPG. Children with DIPG who did not receive any treatment had a median survival of just 3 months. Children who had only radiation lived for a median of 10.4 months from diagnosis. Those treated with both radiation and chemotherapy had a median survival of 11.7 months. These numbers are horrific and show that new treatments are urgently and desperately needed. If the Promising Pathway Act was passed, we would have better treatments right now.